Navigation Links
ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Date:10/28/2009

and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Disclosure Notice

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events. Forward looking statements in this press release include our financial guidance for 2009, and statements regarding our clinical development programs, the effectiveness of our Vancocin and Cinryze sales efforts, our ability to continue to execute a successful launch of Cinryze, our ability to develop life cycle management plans for Cinryze, including designing and commencing clinical studies for additional indications, seeking rights to additional geographic territories and pursuing regulatory approvals in such territories.

We have opposed both the substance of the FDA's bioequivalence method and the manner in which it was developed. The FDA convened a meeting of its Advisory Committee for Pharmaceutical Science and
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
2. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
3. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
4. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
5. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
6. ViroPharma Announces Discontinuation of HCV-796 Development
7. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
8. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. ViroPharma to Present at the Natixis Bleichroeder Conference
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  The Partnership to Fight Chronic Disease (PFCD) released a public ... and a new study analyzing the impact of increased cost sharing ... coalition working to educate policy makers and the public on the ... focused on how the Iowa healthcare exchange ...
(Date:1/23/2015)... Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. biotechnology ... solid tumor cancers, announced today that CEO Linda Powers ... Immunotherapy Forum in Washington D.C. ... January 26 at 10:30 a.m. EST at the Grand Hyatt ...
(Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... , , SAN DIEGO , Feb. ... that the jury in the litigation filed by Lightlab Imaging, Inc. ... Massachusetts , Suffolk County reached a verdict against ... 2008 , Volcano acquired Axsun, which had an agreement to supply ...
... , COLUMBUS, Ohio , Feb. 4 Mettler-Toledo International ... 2009.  Provided below are the highlights: , Sales in local ...  Reported sales growth was 0% due to a 5% benefit from currency. ... were $2.01 , compared with $1.84 in the fourth ...
Cached Medicine Technology:Volcano Corporation Announces Litigation Status 2Volcano Corporation Announces Litigation Status 3Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 2Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 3Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 4Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 5Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 6Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 7Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 8Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 9Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 10Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 11Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 12Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 13Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 14Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 15
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... Wales health department in Australia chose to understand the relationship ... ,The study conducted over three years covered a gamut of ... that a greater proportion of people born in Italy and ... Zealanders were physically more active than other ethnic groups. People ...
... condition in children. Children suffering from insomnia //and hypersomnia ... normal sleep. ,Sleep-disturbed children, with both insomnia ... than those with either insomnia or hypersomnia. ... and colleagues of the University of Pittsburgh, 553 children ...
... lawsuits can significantly slow or halt science's ability ... //factors produced by industry, a team of scientists ... ,The authors caution that litigation's effects could seriously ... a wide variety of diseases, including Parkinson's disease, ...
... discovered that a tiny piece of genetic code apparently goes ... gets there under its own internal code. ,MicroRNAs, already ... gum up larger strands of RNA that carry instructions for ... are, says Joshua Mendell, M.D., Ph.D., an assistant professor in ...
... joining a sugar to a short-chain fatty acid compound, ... that kills cancer // cells in lab tests. The ... been tested on animals or humans. Nevertheless, they believe ... deadly disease. ,“For a long time, ...
... Preston Mason and colleagues at Elucida Research has ... in nature, shows significant promise as a viable ... disease based on its exceptional antioxidant properties in ... and anecdotal human data, the results of the ...
Cached Medicine News:Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 2Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 3Health News:Renegade RNA: Clues to Cancer and Normal Growth 2Health News:Hybrid Molecule Causes Cancer Cells to Self-Destruct 2Health News:Hybrid Molecule Causes Cancer Cells to Self-Destruct 3Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 2Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 3
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
Comprehensive and structured clinical resource with access to more than 1,000 medical and surgical conditions, fully indexed with more than 7,500 items and medications....
... with BD Xstar Blade includes a specially ... blade in prodedure and handling. The ... grind-less process for manufacturing surgical blades. ... consistency. The arch style, single-bevel geometry ...
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists....
Medicine Products: